new edison report, page-2

In reading that announcement seems that all this deal gives at the moment is guaranteed funding for the life of the deal on the research of their particular targets. That is good as they are obviously not trying to find a result using their own money, but ultimately as with the other deals unless they actually find something it is just maintenance money. Maybe thats why the reactions to these deals are becoming less positive as people realise that without a descovery the deal just allows cash sustaibability on that area of research only, possibly even limits them looking in other areas as other areas are unfounded. From existing deals still no clinical trials and the longer it tajes the more muted the reaction to new deals. Cone on pyc, all we need is one peptide that is commercially viable for one of these partners. Even then there might not be much of a bidding war cos the discovered peptide would obky be of use to the company whose target it suited, meaning the best case scenario might be substantial royalties many years from now. could be a long wait on this one.